About Maxwellia
Our Brands
Our Partners
Healthcare Professionals
Investors
News
More
NAPROSYN® PAIN RELIEF COMMISSIONS “REAL INJURY TIME” REPORT ON INJURY PATTERNS, INCIDENCE RATES & REHAB IN PROFESSIONAL FOOTBALL.
ANNA MAXWELL WINS INNOVATION ENTREPRENEUR ACCOLADE -
GREAT BRITISH ENTREPRENEUR AWARDS
MAXWELLIA LAUNCHES NAPROSYN® PAIN RELIEF, A 'GAME-CHANGER' FOR BACK, MUSCLE & JOINT PAIN
ANNA MAXWELL WINS 'INDUSTRY LEADER ROLE MODEL' AT WOMEN IN PHARMA AWARDS
EVANA® WINS 'PRODUCT LAUNCH OF THE YEAR' AT THE PHARMACY PRODUCT OF THE YEAR AWARDS 2025
MAXWELLIA LAUNCHES TV CAMPAIGN FOR EVANA® HEAVY PERIOD RELIEF
BREAKING BARRIERS: CELEBRATING INTERNATIONAL WOMEN'S DAY WITH MAXWELLIA
MAXWELLIA WELCOMES RENEWED GOVERNMENT FOCUS ON MEDICINE RECLASSIFICATION
CHC LEADERS INSIGHTS: ANNA MAXWELL SHARES HER VISION FOR 2025 WITH HBW INSIGHTS
MAXWELLIA SHORTLISTED FOR FOUR CATEGORIES AT OTC MARKETING AWARDS 2024
MAXWELLIA CEO ANNA MAXWELL NOMINATED FOR 2025 NORTHERN POWER AWARDS
SHAPE THE FUTURE OF CONSUMER HEALTHCARE: MAXWELLIA ANNOUNCES EXCLUSIVE INVESTMENT OPPORTUNITY
PUCKERING UP TO PERIODS – EVANA® LAUNCHES UNEXPECTED MENSTRUAL HEALTH CAMPAIGN FOLLOWING CONCERNING SURVEY RESULTS
TACKLING ‘PERIOD INEQUITY’: NEW OVER-THE-COUNTER MEDICINE BRAND LAUNCHES FOR MILLIONS OF WOMEN WHO SUFFER WITH DISRUPTIVE HEAVY PERIODS
MAXWELLIA UNVEILS BOLD PERIOD PAIN CAMPAIGN AT WATERLOO TRAIN STATION
MAXWELLIA CELEBRATES DOUBLE WIN AT PROLIFIC NORTH CHAMPION AWARDS
MAXWELLIA REVOLUTIONISES MENSTRUAL HEALTH CATEGORY IN PHARMACY
MAXWELLIA LAUNCHES LOVITEST™: A CONVENIENT AT-HOME STI TESTING SOLUTION
LOVIONE® WINS PHARMACY PRODUCT OF THE YEAR – CONSUMERS’ CHOICE 2024!
FORTY YEARS OF RECLASSIFICATION
INTRODUCING LOVIONE® A NEW BRAND OF EMERGENCY CONTRACEPTION
SWITCH UP TO SELF-CARE: SELF-CARE DAY 2023
AI INFLUENCER TACKLES TIKTOK HEALTH TREND
CONTRACEPTION IN PHARMACY. WHY WAIT? MAY 2023
MHRA DECISION ON AQUIETTE RECLASSIFICATION MAY 2023
WORLD PHARMACISTS DAY 2022: PHARMACY IN ACTION FOR A HEALTHIER WORLD
MAXWELLIA CEO, ANNA MAXWELL HAS BEEN APPOINTED A FELLOW OF THE ROYAL PHARMACEUTICAL SOCIETY
FORMER PHARMACY SUPERINTENDENT JANICE PERKINS RESPONDS TO AQUIETTE PUBLIC CONSULTATION
®
PUBLIC CONSULTATION ANNOUNCED FOR MAXWELLIA’S SECOND WOMEN’S HEALTH PRODUCT
DR JULIAN SPINKS RESPONDS TO AQUIETTE PUBLIC CONSULTATION – FOR HEALTH CARE PROFESSIONALS
IAN ADAMSON JOINS MAXWELLIA AS STRATEGIC ADVISOR
MAXWELLIA UNVEILS BOLD £3M 360° SUPPORT CAMPAIGN TO DRIVE AWARENESS OF ITS CONTRACEPTIVE PILL LOVIMA
CHANNEL 4 VENTURES INVESTS IN MAXWELLIA – THE LEADING MEDICINES SWITCH COMPANY
GAME CHANGER
Anna Maxwell, the founder and CEO of Maxwellia, tells Breakthrough how her pioneering business will widen access to medicine.
PUSHING THE ON SWITCH
New brands , new pharmacy categories. Next... watch this space.
WOMEN CAN BUY MAXWELLIA’S LOVIMA® CONTRACEPTIVE PILL FROM PHARMACIES WITHOUT A PRESCRIPTION FOR FIRST TIME IN UK HISTORY
Wider availability of desogestrel welcomed by UK’s leading women’s health organisations
MAXWELLIA MAKES ‘MOST EXCITING COMPANIES’ LIST IN NORTH WEST BUSINESS INSIDER MAGAZINE
POWERING UP PHARMACIES
How the High Street hubs can help futureproof the NHS
MAXWELLIA SECURES £500K BRITISH GOVERNMENT BACKED FUTURE FUND INVESTMENT
PRAETURA LEADS SELF CARE FIRM INVESTMENT ROUND
PUBLIC CONSULTATION ANNOUNCED FOR MAXWELLIA’S FIRST WOMEN’S HEALTH PRODUCT
OUR CEO TALKS TO HBW INDUSTRY INSIGHT ABOUT MAXWELLIA’S TRANSITION INTO A CONSUMER HEALTHCARE COMPANY
BIOCITY FEATURE MAXWELLIA CEO ON IWD 2021 CHALLENGING ACCESS TO CONTRACEPTION
SPEARHEADING SHIFT TO SELF CARE WITH THREE PHARMACY PRODUCTS IN LAUNCH PIPELINE
Pharmacists at heart of nation's public health
TOP MOVER AND SHAKER IN BIOBUSINESS 2019
Our CEO and founder, Anna Maxwell has been listed in the top 50 movers and shakers of 2019 by BioBusiness
BIOCITY INVESTS IN MAXWELLIA
Life science incubator and business collective BioCity has announced an investment in Alderley Park-based Maxwellia
POM TO P SWITCHES: WHAT MADE MALOFF PROTECT AND ELLAONE A SUCCESS?
C+D deputy editor Grace Lewis spoke to Anna Maxwell, CEO of Maxwellia, about what makes a successful POM to P change
THE POWER OF ALIGNING YOUR BUSINESS TO A GLOBAL GOAL
Maxwellia is mentioned in Forbes for aligning to Global Goal 3 Good Health
MAXWELLIA EXPANDS TEAM OF SWITCH EXPERTS AS IT BUILDS THE PRODUCT PIPELINE
Appointments will expedite conversion of prescription medicines to over the counter
UK IS FERTILE GROUND FOR SWITCHING
With the recent switch of Pfizer’s Viagra, the UK has shown itself to be an open and progressive market for prescription-to-OTC reclassification.
MAXWELLIA ANNOUNCES FUNDING TO ACCELERATE ITS MISSION FOR SELF CARE
Investment will expedite conversion of prescription medicines to over the counter
.png)
